StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$300.43−10.47 (-3.37%)

Close on Nov 20, 2026Market cap $8.39BP/E –Yield –

Praxis Precision Medicines gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Praxis Precision Medicines

Praxis Precision Medicines has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Praxis Precision Medicines figures

See a number that looks wrong?